SynthesisBMC neurology2026
Assessing the role of Subacute Encephalopathy with Seizures in Alcoholics (SESA) syndrome in the development of status epilepticus: a case report and systematic review with individual patients' analysis.
Synthesis in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubacute Encephalopathy with Seizures in Alcoholics (SESA) is a rare neurological syndrome characterized by altered mental status, periodic EEG discharges, and neuroimaging abnormalities, typically occurring in individuals with chronic alcohol use. Its progression to status epilepticus (SE), including refractory and super-refractory forms, is poorly documented.
methodsWe present a super-refractory status epilepticus (SRSE) case in a patient with confirmed SESA and conduct a systematic review of the literature to explore the relationship between SESA and SE. A systematic literature review was performed using MEDLINE (accessed through PubMed), Scopus, EMBASE and Google Scholar, in accordance with the PRISMA guidelines. Data were extracted on demographics, EEG and imaging findings, treatment approaches, and outcomes.
resultsOur patient developed SRSE in the setting of chronic hepatic dysfunction. The patients responded to a combination of propofol and ketamine and obtained long-term seizure control with vagus nerve stimulation (VNS). Type 3 oligoclonal bands were detected in the CSF, although it is considered a non-specific marker of neuroinflammation. The literature review identified 7 cases of SE in SESA, with variable clinical presentations. While levetiracetam and valproic acid were the most employed treatments, benzodiazepines were notably absent from first-line protocols. Phenytoin and lacosamide resulted as favorable alternatives.
conclusionSE in the context of SESA requires tailored therapeutic strategies due to hepatic comorbidities and diagnostic ambiguity with NCSE. Our report supports the cautious use of propofol and ketamine in SRSE, as well as the efficacy of VNS in long-term seizure control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.